Financials

News Discussions Technicals Forecast Seasonals

1061 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ESSEX BIO-TECHNOLOGY operating, investing, and financing activities

1061 free cash flow for H2 24 is 145.05 M HKD. For 2024, 1061 free cash flow was 270.05 M HKD and operating cash flow was 314.45 M HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—